TP53 and cancer: In the case of prostate cell lines, an increased expression of the TP53 gene was observed in LC50-treated cancer cells, while in both cell lines, in the highest tested concentrations, a decrease in gene expression was observed (in the case of RWPE-1, expression of TP53 was not observed).